Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Accumulated Expenses (2024 - 2025)

Xenetic Biosciences (XBIO) has disclosed Accumulated Expenses for 4 consecutive years, with $100000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accumulated Expenses fell 66.67% year-over-year to $100000.0, compared with a TTM value of $100000.0 through Sep 2025, down 66.67%, and an annual FY2024 reading of $200000.0, changed N/A over the prior year.
  • Accumulated Expenses was $100000.0 for Q3 2025 at Xenetic Biosciences, roughly flat from $100000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $800000.0 in Q2 2024 and bottomed at $100000.0 in Q2 2025.